Genetic/Familial High-Risk Assessment: Breast and Ovarian, Version 2.2015.

نویسندگان

  • Mary B Daly
  • Robert Pilarski
  • Jennifer E Axilbund
  • Michael Berry
  • Saundra S Buys
  • Beth Crawford
  • Meagan Farmer
  • Susan Friedman
  • Judy E Garber
  • Seema Khan
  • Catherine Klein
  • Wendy Kohlmann
  • Allison Kurian
  • Jennifer K Litton
  • Lisa Madlensky
  • P Kelly Marcom
  • Sofia D Merajver
  • Kenneth Offit
  • Tuya Pal
  • Huma Rana
  • Gwen Reiser
  • Mark E Robson
  • Kristen Mahoney Shannon
  • Elizabeth Swisher
  • Nicoleta C Voian
  • Jeffrey N Weitzel
  • Alison Whelan
  • Myra J Wick
  • Georgia L Wiesner
  • Mary Dwyer
  • Rashmi Kumar
  • Susan Darlow
چکیده

The NCCN Guidelines for Genetic/Familial High-Risk Assessment: Breast and Ovarian provide recommendations for genetic testing and counseling and risk assessment and management for hereditary cancer syndromes. Guidelines focus on syndromes associated with an increased risk of breast and/or ovarian cancer and are intended to assist with clinical and shared decision-making. These NCCN Guidelines Insights summarize major discussion points of the 2015 NCCN Genetic/Familial High-Risk Assessment: Breast and Ovarian panel meeting. Major discussion topics this year included multigene testing, risk management recommendations for less common genetic mutations, and salpingectomy for ovarian cancer risk reduction. The panel also discussed revisions to genetic testing criteria that take into account ovarian cancer histology and personal history of pancreatic cancer.

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Genetic risk assessments in individuals at high risk for inherited breast cancer in the breast oncology care setting.

BACKGROUND It has become increasingly common to consider BRCA mutation status when determining optimal cancer risk management and treatment options in order to improve patient outcomes. Knowledge about the risk for hereditary cancer at or as close as possible to the time of diagnosis allows patients access to the most risk reduction options available. METHODS This paper illustrates the role o...

متن کامل

Towards Evidence-Based Management of Inherited Breast and Breast-Ovarian Cancer

Inherited breast-ovarian cancer was described in 1866. The underlying genetic defects in BRCA1/2 were demonstrated 128 years later. We now have 10 years of experience with genetic testing in BRCA kindreds. The majority of breast cancer kindreds (familial breast cancer) do not demonstrate ovarian cancer and are not associated with BRCA mutations. The effect of early diagnosis and treatment is mo...

متن کامل

Clinical management of women in BRCAX families: issues and controversies

The role of the familial cancer clinic (FCC) is to provide a cancer risk assessment and appropriate cancer risk management advice, but there are certain groups of patients for whom there are no standard risk management guidelines. One such group is women with a strong family history of breast cancer but BRCA genetic testing has not found a germline mutation. As a family history of breast cancer...

متن کامل

Variants in the Signaling Protein TSAd are Associated with Susceptibility to Ovarian Cancer in BRCA1/2 Negative High Risk Families

A substantial fraction of familial ovarian cancer cases cannot be attributed to specific genetic factors. The discovery of additional susceptibility genes will permit a more accurate assessment of hereditary cancer risk and allow for monitoring of predisposed women in order to intervene at the earliest possible stage. We focused on a population with elevated familial breast and ovarian cancer r...

متن کامل

An oncologist-based model of cancer genetic counselling for hereditary breast and ovarian cancer.

BACKGROUND We describe a multistep model of cancer genetic counselling designed to promote awareness, and disease surveillance and preventive measures for hereditary and familial breast and ovarian cancer. PATIENTS AND METHODS Step T0 of the model entails information giving; this is followed by pedigree analysis and risk estimation (T1), risk communication and genetic testing (T2), and geneti...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

عنوان ژورنال:
  • Journal of the National Comprehensive Cancer Network : JNCCN

دوره 14 2  شماره 

صفحات  -

تاریخ انتشار 2006